San Francisco, CA, United States of America

James John Crawford

USPTO Granted Patents = 24 (Patent Applications = 13)

EPO Patents = 16 (Patent Applications = 23)

Average Co-Inventor Count = 3.4

ph-index = 7

Forward Citations = 105(Granted Patents)

Location History:

South San Francisco, CA (US) (2014 - 2021)
San Francisco, CA (US) (2014 - 2023)

Company Filing History:

F. Hoffmann-la Roche Ag

patents

2 out of 6

Rqx Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. D1081295 - Adjustable branch separator device (2025-07-01),

2. 11731943 - Therapeutic compounds, compositions and methods of use thereof (2023-08-22),

3. 11072635 - Macrocyclic broad spectrum antibiotics (2021-07-27),

4. 11008312 - Pyridazine derivatives as RORc modulators (2021-05-18),

5. RE48239 - Heteroaryl pyridone and aza-pyridone compounds (2020-10-05),

6. 10654824 - 2-azabicyclo[3.1.0]hexan-3-one derivatives and methods of use (2020-05-19),

7. 10550117 - 2-azabicyclo[3.1.0]hexan-3-one derivatives and methods of use (2020-02-04),

8. 10392422 - Macrocyclic broad spectrum antibiotics (2019-08-27),

9. 10280144 - Pyridazine derivatives as RORc modulators (2019-05-07),

10. 10045983 - Heteroaryl pyridone and aza-pyrodine compounds (2018-08-14),

11. 9782405 - Heteroaryl pyridone and aza-pyrodine compounds (2017-10-10),

12. 9326985 - Heteroaryl pyridone and aza-pyridone amide compounds (2016-05-03),

13. 9260415 - Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality (2016-02-16),

14. 9238655 - Heteroaryl pyridone and aza-pyridone compounds (2016-01-19),

15. 9115152 - Alkylated piperazine compounds (2015-08-25),

Title: The Innovative Path of James John Crawford

Introduction

James John Crawford is an accomplished inventor based in San Francisco, CA. With a remarkable portfolio of 23 patents, he has significantly contributed to the field of pharmaceuticals and medical innovations. His work revolves around the development of therapeutic compounds and antibiotics that advance healthcare.

Latest Patents

Crawford's latest patents showcase his dedication to creating impactful solutions in medicine. One of his notable inventions is related to therapeutic compounds, specifically compositions and methods of use as Janus kinase inhibitors. These compounds, described in his patent as Compounds of Formula (I), hold promise in treating various diseases. Additionally, he has developed macrocyclic broad-spectrum antibiotics, which include antibacterial compounds that demonstrate broad-spectrum bioactivity. Specifically, these compounds inhibit bacterial type 1 signal peptidase (SpsB), an essential protein for bacterial survival, and offer new pharmaceutical compositions and treatment methods.

Career Highlights

Throughout his career, James John Crawford has made significant strides in the pharmaceutical industry. He has worked with well-known companies, including Genentech, Inc. and Rqx Pharmaceuticals, Inc. His experiences in these organizations have provided him with the knowledge and expertise needed to drive innovation in his field.

Collaborations

Collaboration has been a key aspect of Crawford's career, as reflected in his partnerships with talented individuals in the industry. He has worked alongside esteemed colleagues like Wendy B Young and Daniel Fred Ortwine. These collaborations have undoubtedly influenced his research and development efforts, fostering an environment of shared knowledge and innovation.

Conclusion

James John Crawford's contributions to the realm of pharmaceuticals through his innovative patents are commendable. His work not only highlights his inventive spirit but also his commitment to improving health outcomes through advanced therapeutic solutions. With a strong foundation in both research and industry collaboration, Crawford continues to pave the way for future innovations in medicine.

This text is generated by artificial intelligence and may not be accurate.